As long as this isn't some kind of preemptive stunt like GTAT pulled with their infamous "business update" which turned out to be a bankruptcy announcement, SUNE should be ok - I say 10, maybe high 9s - there could be a relief rally just by not reporting any bad surprises.
I didn't notice this until now. Insider buying throughout August in the $7+ range. Clean Form 4s direct ownership. Not related to compensation or vesting of stock options. Good to see some confidence from inside.
Oil will not stay cheap forever. Now is the time to make the investment, not when oil is higher. Basically, it takes money to make money and those with money, patience, and a plan will keep making the money. Meanwhile, the little players will go out of business.
Also, from a per/share perspective, the net earnings per share will jump about 10% next quarter due to the elimination of the same % of shares.
I loved the idea of using it for cancer treatment. That was a head-shaker since day 1. Yeah, let's put a cancer patient at one end of this 5,000,000 watt laser and just radiate that cancer away. Shucks, it had so much promise in the medical field.
the MM's are filling orders today? What does that have to do with analysts discussing $1.60 per gallon buyout figures? MM are filling share orders not orders to buy out the company. You are not making sense.
Well, yeah. Would like to know why the stock traded 5x normal volume yesterday and up 10% with this news coming. Anyone who says the market is "efficient" is an idiot.
Revenue a bit lower than last year but margins and profit is higher. Yet revenue will be ticking up due to new win and longer-than-expected revenue from a prior win. Could be another banner year.
I saw that, interesting. But "whose" margins and profit are they talking about? is that just a guess on the industry as a whole or is that based on intermediate reporting results from the ethanol producers (which I doubt) ?
Were those written by a bunch of Yahoos? $2.29 EPS per share estimate next year. At a mere 10x multiple, that's $23 per share. Throw some growth in there and we're looking at $30. Yet, stock selling off like no tomorrow.
Therapy (eBX) was about 2/3rd of the revenue. Detection (imaing, etc..) was about 1/3rd of the revenue. The market capitalization has been chopped down to 1/3rd of the previous valuation. Hence, the drop in market cap, on a ballpark estimation, is now valuing the therapy (eBX) side of business at $0.00.
But, isn't the question also, what percentage of skin was in the western states as opposed to non-western states? "Noridian, the Medicare Administrative Contractor in Jurisdictions E and F, which consists of 13 states primarily on the West Coast,...."
I think it has mostly to do with renegotiating new drillship contracts. But, for now, they are highly booked so the profits should roll in for a while. It's the future that is the cause for concern.
Stick a sock in it. Blah blah blah.